Market Size

The Global Cosmetic Surgery Market experienced substantial growth, reaching USD 61.3 billion in 2022, and is poised for further expansion, with projections indicating it could reach USD 132.2 billion by 2031. This growth trajectory is anticipated to be characterized by a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period spanning from 2024 to 2031. 

Cosmetic surgery involves altering or enhancing the natural appearance of various body parts to improve their aesthetic appeal. Qualified surgeons, well-versed in anatomy and tissue structure, typically perform these procedures with meticulous care and precision. 

Such surgeries are usually elective and aim for precise results. They are gaining popularity as individuals seek to enhance their appearance. Additionally, rising instances of dermatological conditions and a growing number of patients seeking treatment contribute to the increasing demand for these procedures in the market. 

 

 
 

Cosmetic Surgery Market Segmentation 

By Procedure 

  • Abdominoplasty 

  • Blepharoplasty 

  • Mammoplasty 

  • Buttock augmentation 

  • Laser Skin Rejuvenation 

  • Face Surgery 

  • Liposuction 

  • Others 

By Product 

  • Implants  

  • Equipment 

  • Hyaluronic acid 

Cosmetic Surgery Companies 

Major key players are AbbVie, Bausch Health Companies, Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH, Sientra, Sinclair Pharma, and Teoxane Laboratories.